AVURETH Trademark

Trademark Overview


On Monday, May 1, 2023, a trademark application was filed for AVURETH with the United States Patent and Trademark Office. The USPTO has given the AVURETH trademark a serial number of 97914675. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 27, 2024. This trademark is owned by Glaxo Group Limited. The AVURETH trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders
avureth

General Information


Serial Number97914675
Word MarkAVURETH
Filing DateMonday, May 1, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2023NEW APPLICATION ENTERED